AbsEn.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Stress et Covid - Exploration (Accueil)

Index « AbsEn.i » - entrée « treatment »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
treating < treatment < treatments  Facettes :

List of bibliographic references indexed by treatment

Number of relevant bibliographic references: 527.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000008 (2020) George Zaki Ghali [États-Unis] ; Michael George Zaki Ghali [États-Unis, Suède]β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma
000014 (2020) Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine][Management of corona virus disease-19 (COVID-19): the Zhejiang experience].
000018 (2020) Massimo Roman[Between intensive care and palliative care at the time of CoViD-19.]
000029 (2020) Janet E. PopeWhat Does the COVID-19 Pandemic Mean for Rheumatology Patients?
000040 (2020) Y-X Wang [République populaire de Chine] ; J-R Ma ; S-Q Wang ; Y-Q Zeng ; C-Y Zhou ; Y-H Ru ; L. Zhang ; Z-G Lu ; M-H Wu ; H. LiUtilizing integrating network pharmacological approaches to investigate the potential mechanism of Ma Xing Shi Gan Decoction in treating COVID-19.
000042 (2020) Qian-Yi Peng ; Xiao-Ting Wang [République populaire de Chine] ; Li-Na ZhangUsing echocardiography to guide the treatment of novel coronavirus pneumonia
000044 (2020) Walter Gottlieb Land [France, Allemagne]Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution
000058 (2020) Prathish K. Rajaraman [États-Unis] ; Jiwoong Choi [États-Unis] ; Eric A. Hoffman [États-Unis] ; Patrick T. O'Shaughnessy [États-Unis] ; Sanghun Choi [Corée du Sud] ; Renishkumar Delvadia [États-Unis] ; Andrew Babiskin [États-Unis] ; Ross Walenga [États-Unis] ; Ching-Long Lin [États-Unis]Transport and deposition of hygroscopic particles in asthmatic subjects with and without airway narrowing
000066 (2020) Marilù Bartiromo [Italie] ; Beatrice Borchi [Italie] ; Annarita Botta [Italie] ; Alfredo Bagalà [Italie] ; Gianmarco Lugli [Italie] ; Marta Tilli [Italie] ; Annalisa Cavallo [Italie] ; Brunilda Xhaferi [Italie] ; Roberta Cutruzzulà [Italie] ; Augusto Vaglio [Italie] ; Silvia Bresci [Italie] ; Aida Larti [Italie] ; Alessandro Bartoloni [Italie] ; Calogero Cirami [Italie]Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19).
000071 (2020) Lei Li [République populaire de Chine] ; Ranran Li [République populaire de Chine] ; Zhixiong Wu [République populaire de Chine] ; Xianghong Yang ; Mingyan Zhao [République populaire de Chine] ; Jiao Liu [République populaire de Chine] ; Dechang Chen [République populaire de Chine]Therapeutic strategies for critically ill patients with COVID-19
000087 (2020) Yi-Chi Wu [République populaire de Chine] ; Ching-Sung Chen [République populaire de Chine] ; Yu-Jiun Chan [République populaire de Chine]The outbreak of COVID-19: An overview
000092 (2020) Kenneth Maiese [États-Unis]The mechanistic target of rapamycin (mTOR): Novel Considerations as an Antiviral Treatment and Possibilities for COVID-19.
000107 (2020) Jinping Zhang [République populaire de Chine] ; Peng Liu [République populaire de Chine] ; Morong Wang [République populaire de Chine] ; Jie Wang [République populaire de Chine] ; Jie Chen [République populaire de Chine] ; Wenling Yuan [République populaire de Chine] ; Mei Li [République populaire de Chine] ; Zhijuan Xie [République populaire de Chine] ; Wangping Dong [République populaire de Chine] ; Hongye Li [République populaire de Chine] ; Yan Zhao [République populaire de Chine] ; Lun Wan [République populaire de Chine] ; Tian Chu [République populaire de Chine] ; Lu Wang [République populaire de Chine] ; Hui Zhang [République populaire de Chine] ; Ting Tao [République populaire de Chine] ; Jing Ma [République populaire de Chine]The clinical data from 19 critically ill patients with coronavirus disease 2019: a single-centered, retrospective, observational study
000108 (2020) Weiyi Tan ; Jamil AboulhosnThe cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
000110 (2020) Carlo Perricone [Italie] ; Paola Triggianese [Italie] ; Elena Bartoloni [Italie] ; Giacomo Cafaro [Italie] ; Angelo F. Bonifacio [Italie] ; Roberto Bursi [Italie] ; Roberto Perricone [Italie] ; Roberto Gerli [Italie]The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
000113 (2020) Peter P. Liu [Canada] ; Alice Blet [France] ; David Smyth [Canada] ; Hongliang Li [République populaire de Chine]The Science Underlying COVID-19: Implications for the Cardiovascular System.
000127 (2020) Osama M. Al-Quteimat ; Amer Mustafa Amer [Jordanie]The Impact of the COVID-19 Pandemic on Cancer Patients
000147 (2020) Jonathan R. Erlich [Australie] ; Eunice E. To [Australie] ; Stella Liong [Australie] ; Robert Brooks [Australie] ; Ross Vlahos [Australie] ; John J. O'Leary [Australie] ; Doug A. Brooks [Australie] ; Stavros Selemidis [Australie]Targeting Evolutionary Conserved Oxidative Stress and Immunometabolic Pathways for the Treatment of Respiratory Infectious Diseases.
000153 (2020) Jiabao Xu ; Shizhe Zhao ; Tieshan Teng ; Abualgasim Elgaili Abdalla ; Wan Zhu ; Longxiang Xie ; Yunlong Wang [République populaire de Chine] ; Xiangqian GuoSystematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
000157 (2020) Louis W. Lim [Singapour] ; Leonard W. Yip [Singapour] ; Hui Wen Tay [Singapour] ; Xue Ling Ang [Singapour] ; Llewellyn K. Lee [Singapour] ; Chee Fang Chin [Singapour] ; Vernon Yong [Singapour]Sustainable practice of ophthalmology during COVID-19: challenges and solutions
000173 (2020) Lisa A. Eaton [États-Unis] ; Seth C. Kalichman [États-Unis]Social and behavioral health responses to COVID-19: lessons learned from four decades of an HIV pandemic

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "treatment" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "treatment" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    treatment
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021